We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2025
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Prostate Cancer Markers Based on Chemical Make-Up of Calcifications to Speed Up Detection

By LabMedica International staff writers
Posted on 25 Jul 2025

Prostate cancer can be difficult to detect early, limiting timely and appropriate treatment. While calcification—calcium build-up in soft tissues—has previously been suggested as a possible indicator, it remains underexplored. Diagnosing the disease accurately and quickly is essential to improving patient outcomes and reducing the need for invasive treatments such as surgery. Researchers have now found that certain chemical elements within calcifications appear to be linked to how aggressive the cancer is. Analyzing the chemical composition of these calcifications could provide new markers to help doctors identify the disease sooner.

The research team at Keele University (Keele, EN, UK; www.keele.ac.uk) had previously demonstrated that calcifications could signal prostate cancer. In their latest study, the researchers expanded on that work by analyzing their chemical composition. To do this, researchers used the Diamond Light Source synchrotron in Oxford to examine calcified prostate tissue at a highly detailed level. Their investigation focused on identifying the elements present within the calcifications and exploring whether any correlations existed with tumor severity.


Image: Researchers are studying the chemical make-up of calcifications to improve cancer detection strategies (Gosling et al., Chem. Biomed. Imaging, 2025, DOI: 10.1021/cbmi.5c00050)
Image: Researchers are studying the chemical make-up of calcifications to improve cancer detection strategies (Gosling et al., Chem. Biomed. Imaging, 2025, DOI: 10.1021/cbmi.5c00050)

In their study published in ACS Chemical & Biomedical Imaging - Bioimaging of Metals, the researchers reported that elements such as iron, copper, nickel, manganese, and chromium were associated with the tumor’s Grade Group classification. These findings indicate that the presence of certain elements could serve as early warning signs of cancer aggression. The simplicity of detecting such markers could eventually lead to personalized treatment plans and reduce reliance on invasive interventions. The researchers plan to build on this discovery by developing new diagnostic markers based on elemental analysis of prostate tissue, aiming to detect cancer earlier and help doctors determine the most appropriate treatment path for each patient.

“For the first time in prostate tissue, we’ve been able to look closely at what these tiny calcium deposits are made of, and we’ve found that certain elements seem to be linked to how aggressive the cancer is. That’s really exciting because it means we might be able to use these elements as early warning signs,” said Dr. Charlene Greenwood, co-lead author of the study. “The hope is that this research will lead to better ways to spot prostate cancer earlier and help doctors decide on the best treatment for each patient, potentially avoiding more invasive procedures.”


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Sample Transportation System
Tempus1800 Necto
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II

Latest Clinical Chem. News

Breath Test Could Help Detect Blood Cancers
25 Jul 2025  |   Clinical Chem.

ML-Powered Gas Sensors to Detect Pathogens and AMR at POC
25 Jul 2025  |   Clinical Chem.

Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation
25 Jul 2025  |   Clinical Chem.



PURITAN MEDICAL